ストックスクリーナーアプリを入手
4.13
0.24%
0.010
Oramed Pharmaceuticals Inc (ORMP) 最新ニュース
Barron's lists USD 7.00 target for Oramed Pharmaceuticals stock - AD HOC NEWS
Oramed Pharmaceuticals Inc (OJU1.DU) stock price, news, quote and history - Yahoo Finance UK
Oramed Pharmaceuticals schedules November 12 results for Oramed Pharmaceuticals stock - ad-hoc-news.de
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Oramed Pharmaceuticals stock fell 3.74 percent as targets rose - AD HOC NEWS
Oramed Pharmaceuticals Inc (OJU1.DU) stock price, news, quote and history - Yahoo Finance Australia
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com Australia
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals (ORMP) CFO Avraham Gabay Sells 20,000 Sha - GuruFocus
Oramed COO & CBO Joshua Hexter sells $135,330 in shares By Investing.com - Investing.com Nigeria
Oramed COO & CBO Joshua Hexter sells $135,330 in shares By Investing.com - Investing.com South Africa
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com India
Oramed COO & CBO Joshua Hexter sells $135,330 in shares - Investing.com
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock - Investing.com
A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. - Stock Titan
Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. - Stock Titan
Form 4 Oramed Pharmaceuticals Inc For: 2 October By Investing.com - Investing.com UK
Form 144 ORAMED PHARMACEUTICALS INC. For: 1 October By Investing.com - Investing.com Nigeria
Form 144 ORAMED PHARMACEUTICALS INC. For: 1 October By Investing.com - Investing.com Canada
An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. - Stock Titan
A trading plan underpins an officer's proposed $140K share sale at Oramed (ORMP). - Stock Titan
40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. - Stock Titan
Six option grants were canceled in exchange for a fully vested stock award to Oramed (ORMP) CEO Nadav Kidron. - Stock Titan
Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to S&P Global BMI Index - marketscreener.com
Oramed Pharmaceuticals stock trades quietly as investors weigh recent trial progress - AD HOC NEWS
Oramed Pharmaceuticals Inc.Common Stock (Nasdaq:ORMP) Detailed Stock Data - The Chronicle-Journal
Form 8K Oramed Pharmaceuticals Inc For: 17 September By Investing.com - Investing.com Nigeria
Form 8K Oramed Pharmaceuticals Inc For: 17 September By Investing.com - Investing.com UK
Oramed Pharmaceuticals (ORMP) moves to three-year pay votes - Stock Titan
Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting - Investing.com
Oramed shifts focus to investments, sees gains but faces cash and dilution risks - Pluang
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) - Seeking Alpha
Oramed Pharmaceuticals (ORMP) Slips to $4.76, Holding Above $4.52 SupportIV Rank - careplusvn.com
Oramed backs exoskeleton maker Lifeward (NASDAQ: LFWD) in milestone-based funding deal - Stock Titan
Oramed Pharmaceuticals (ORMP) Rises 3.2% to $5.0, Testing Key $5.25 ResistanceTPO Profile - vinanet.vn
Oramed Pharmaceuticals (ORMP) Rises 3.2% to $5.0, Testing Key $5.25 ResistanceConversion Trade - siam.in
Oramed Pharmaceuticals stock holds at $5 after recent biotech volatility - ad-hoc-news.de
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness - Yahoo Finance
Biotech Stocks At 52-Week HighsNEO, BLSM, RVMD, ORMP, CADL - RTTNews
Oramed Pharmaceuticals Incorporated Actuals & Estimates (TRADEGATE:OJU1) - TradingView
Top Penny Stocks To Watch In August 2026 - simplywall.st
Top Penny Stocks To Watch In August 2026 - simplywall.st
Oramed (ORMP) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Post-Earnings: The Stock Ends Up 4.60% on the DayDividend Earnings Report - vinanet.vn
Oramed (ORMP) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Post-Earnings: The Stock Ends Up 4.60% on the DayMid-Term Outlook - dars.gov.et
Nano Dimension Names Nadav Kidron to Board, Exclusivity with Infinite Epigenetics Ends - Kalkine Media
Nano Dimension Appoints Nadav Kidron to Lead Capital Allocation Review - citybiz
Oramed CEO Joins Nano Dimension Board as Directors Weigh Capital Options - Stock Titan
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee - Yahoo Finance
ORMP Price Today: Oramed Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC
3.09%
0.72%
大文字化:
|
ボリューム (24 時間):